Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
WisdomTree BioRevolution Fund (WDNA) and Global X Genomics & Biotechnology ETF - USD (GNOM) belong to the same industry segment: BioTech & Genomics. WDNA's top 3 sector exposures are Health Care, Materials and Consumer Staples. In contrast, GNOM's top sector exposures are Health Care, WDNA is less expensive with a Total Expense Ratio (TER) of 0.45%, versus 0.5% for GNOM. WDNA is up 4.96% year-to-date (YTD) with -$357K in YTD flows. GNOM performs worse with -0.99% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of WDNA and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | WDNA GNOM | -0.46%-2.35% | +4.60%-3.29% | +4.96%-0.99% | +38.09%+29.80% | +12.49%-6.02% | n/a-51.80% |
| Flows | WDNA GNOM | -$357K- | -$357K-$4M | -$357K-$2M | -$357K-$19M | -$524K-$115M | -+$11M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | WDNA GNOM | +22.81%+23.45% | +28.57%+30.08% | +24.57%+28.53% | n/a+33.47% |
| Max drawdown | WDNA GNOM | -8.60%-10.89% | -17.47%-22.14% | -37.80%-46.50% | n/a-72.17% |
| Max drawdown duration | WDNA GNOM | 48d48d | 106d113d | 901d1031d | n/a1714d |
WDNA | GNOM | |
Last sale 3/12/2026 at 1:30 PM | $17.25 | $43.93 |
| Previous close 03/11/2026 | $17.67 | $45.00 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
WDNA | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
WDNA | GNOM | |
|---|---|---|
| Last price | $17.25 | $43.93 |
| 1D performance | -2.35% | -2.38% |
| AuM | $2.31 M | $49.36 M |
| E/R | 0.45% | 0.5% |
WDNA | GNOM | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | WisdomTree | Global X |
| Benchmark | WisdomTree BioRevolution Index | Solactive Genomics Index |
| N° of holdings | 75 | 46 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 3, 2021 | April 5, 2019 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
